IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 145 filers reported holding IMMUNOGEN INC in Q1 2016. The put-call ratio across all filers is 0.70 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $83,000 | -91.2% | 40,731 | -88.4% | 0.05% | -91.7% |
| Q3 2016 | $942,000 | -13.0% | 351,565 | 0.0% | 0.65% | -18.8% |
| Q2 2016 | $1,083,000 | -24.5% | 351,565 | +108.9% | 0.80% | -24.2% |
| Q1 2016 | $1,434,000 | -37.5% | 168,315 | -0.4% | 1.05% | -37.7% |
| Q4 2015 | $2,293,000 | +43.0% | 168,990 | +1.2% | 1.69% | +32.5% |
| Q3 2015 | $1,603,000 | -32.8% | 167,025 | +0.7% | 1.27% | -25.2% |
| Q2 2015 | $2,386,000 | +59.0% | 165,925 | -1.0% | 1.70% | +57.8% |
| Q1 2015 | $1,501,000 | +124.4% | 167,665 | +52.9% | 1.08% | +128.3% |
| Q4 2014 | $669,000 | -34.7% | 109,635 | +13.4% | 0.47% | -34.7% |
| Q3 2014 | $1,024,000 | +7.2% | 96,700 | +20.1% | 0.72% | +6.3% |
| Q2 2014 | $955,000 | -19.9% | 80,525 | -0.9% | 0.68% | -33.4% |
| Q1 2014 | $1,192,000 | 0.0% | 81,225 | 0.0% | 1.02% | 0.0% |
| Q4 2013 | $1,192,000 | – | 81,225 | – | 1.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 10,906,962 | $69,914,000 | 3.04% |
| Fernwood Investment Management, LLC | 224,500 | $1,439,000 | 0.77% |
| Telemetry Investments, L.L.C. | 272,000 | $1,744,000 | 0.66% |
| Schonfeld Strategic Advisors LLC | 865,356 | $5,547,000 | 0.45% |
| Virtus ETF Advisers LLC | 53,977 | $346,000 | 0.43% |
| Endurant Capital Management LP | 210,800 | $1,351,000 | 0.41% |
| SPHERA FUNDS MANAGEMENT LTD. | 500,000 | $3,205,000 | 0.38% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 113,216 | $726,000 | 0.37% |
| Orbimed Advisors | 2,834,126 | $18,167,000 | 0.23% |
| PINNACLE ASSOCIATES LTD | 1,322,231 | $8,476,000 | 0.16% |